Prenetics Global旗下IM8部门交出了一份亮眼的二季度成绩单——营收同比增长高达288%。基于这一强劲势头，公司已将2026财年IM8营收指引大幅上调至2.2亿至2.3亿美元区间。
值得关注的是，今年7月成为公司合并口径下调整后自由现金流转正的首个月份。管理层预计，这一积极趋势将在第三季度及此后得以延续。
从营收增速来看，IM8的爆发式增长无疑为Prenetics整体业务注入了强劲动能。上调后的全年指引较此前预期显著提升，反映出管理层对该业务线持续增长的充足信心。
现金流转正的意义不容小觑。对于正处于业务扩张期的公司而言，实现自由现金流的持续为正，往往被视为经营进入良性循环的重要信号。Prenetics方面表示，7月的数据标志着公司财务健康状况的转折点，而展望未来，三季度及后续季度预计都将保持这一向好态势。
业内分析人士指出，IM8的快速增长与公司战略布局的推进密切相关，而现金流状况的改善则为后续业务拓展提供了更坚实的财务基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.